drugset / Trial / NCT05671796

Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury

NCT05671796

RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to evaluate the efficacy and safety of intrathecal administration of autologous mesenchymal stem cells in participants with subacute spinal cord injury.

Timeline

Start
2023-04-01
Primary completion
2023-09-25
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 5e+07 cells Intrathecal

Indications